# Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tofacitinib-in-combination-with-nonbiologic-disease-modifying-antirheumatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joel M. Kremer,Zhanguo Li,Stephen Hall,Roy Fleischmann,Mark C. Genovese,E. Martín‐Mola,John D. Isaacs,David Gruben,Gene V. Wallenstein,Sriram Krishnaswami,Samuel H. Zwillich,Tamás Koncz,Richard J. Riese,John Bradley |
| Citations | 450 |
| DOI | 10.7326/0003-4819-159-4-201308200-00006 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2149447280 |
| PMID | 24026258 |
| Type | article |
| Year | 2013 |

## Paper authors

- [David Gruben](https://scholariq.org/researchers/david-gruben/)

## Paper journal

- [Annals of Internal Medicine](https://scholariq.org/journals/annals-of-internal-medicine/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.